Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Increased stress associated with head-out plethysmography testing can exacerbate respiratory effects and lead to mortality in rats.

Lynch JJ 3rd, Rossignol E, Moehrle JJ, Van Vleet TR, Marsh KC, Parman T, Mirsalis J, Ottinger SE, Segreti JA, Rao M, Mittelstadt SW.

J Pharmacol Toxicol Methods. 2019 Sep - Oct;99:106580. doi: 10.1016/j.vascn.2019.106580. Epub 2019 May 11.

PMID:
31085318
2.

Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.

Wu S, Yuen F, Swerdloff RS, Pak Y, Thirumalai A, Liu PY, Amory JK, Bai F, Hull L, Blithe DL, Anawalt BD, Parman T, Kim K, Lee MS, Bremner WJ, Page ST, Wang C.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):629-638. doi: 10.1210/jc.2018-01528.

3.

Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.

Song B, Liu Y, Parman T, Liu S, Miller JK, Liu X, Tanga MJ, Mirsalis J.

J Proteome Res. 2014 Dec 5;13(12):5909-17. doi: 10.1021/pr500835w. Epub 2014 Nov 7.

4.

Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats.

Davis M, Bunin DI, Samuelsson SJ, Altera KP, Kinders RJ, Lawrence SM, Ji J, Ames MM, Buhrow SA, Walden C, Reid JM, Rausch LL, Parman T.

Toxicol Pathol. 2015 Jun;43(4):519-29. doi: 10.1177/0192623314548766. Epub 2014 Oct 1.

5.

Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.

Schweikart KM, Eldridge SR, Safgren SL, Parman T, Reid JM, Ames MM, Goetz MP, Davis MA.

Toxicol Pathol. 2014 Dec;42(8):1188-96. doi: 10.1177/0192623314525688. Epub 2014 Mar 26.

6.

Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys.

Liu Y, Parman T, Schneider B, Song B, Galande AK, Anderson D, Mirsalis J.

J Proteome Res. 2013 Apr 5;12(4):1830-7. doi: 10.1021/pr3011809. Epub 2013 Mar 28.

7.

Lead optimization of antimalarial propafenone analogues.

Lowes D, Pradhan A, Iyer LV, Parman T, Gow J, Zhu F, Furimsky A, Lemoff A, Guiguemde WA, Sigal M, Clark JA, Wilson E, Tang L, Connelly MC, Derisi JL, Kyle DE, Mirsalis J, Guy RK.

J Med Chem. 2012 Jul 12;55(13):6087-93. doi: 10.1021/jm300286a. Epub 2012 Jun 29.

8.

Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice.

Bermudez LE, Inderlied CB, Kolonoski P, Chee CB, Aralar P, Petrofsky M, Parman T, Green CE, Lewin AH, Ellis WY, Young LS.

Antimicrob Agents Chemother. 2012 Aug;56(8):4202-6. doi: 10.1128/AAC.00320-12. Epub 2012 May 21.

9.

Evaluation of arylimidamides DB1955 and DB1960 as candidates against visceral leishmaniasis and Chagas' disease: in vivo efficacy, acute toxicity, pharmacokinetics, and toxicology studies.

Zhu X, Liu Q, Yang S, Parman T, Green CE, Mirsalis JC, de Nazaré Correia Soeiro M, Mello de Souza E, da Silva CF, da Gama Jaen Batista D, Stephens CE, Banerjee M, Farahat AA, Munde M, Wilson WD, Boykin DW, Wang MZ, Werbovetz KA.

Antimicrob Agents Chemother. 2012 Jul;56(7):3690-9. doi: 10.1128/AAC.06404-11. Epub 2012 Apr 16.

10.

Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.

Zhang Y, Clark JA, Connelly MC, Zhu F, Min J, Guiguemde WA, Pradhan A, Iyer L, Furimsky A, Gow J, Parman T, El Mazouni F, Phillips MA, Kyle DE, Mirsalis J, Guy RK.

J Med Chem. 2012 May 10;55(9):4205-19. doi: 10.1021/jm201642z. Epub 2012 Apr 18.

11.

Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity.

Parman T, Bunin DI, Ng HH, McDunn JE, Wulff JE, Wang A, Swezey R, Rasay L, Fairchild DG, Kapetanovic IM, Green CE.

Toxicol Sci. 2011 Dec;124(2):487-501. doi: 10.1093/toxsci/kfr238. Epub 2011 Sep 13.

12.

Novel arylimidamides for treatment of visceral leishmaniasis.

Wang MZ, Zhu X, Srivastava A, Liu Q, Sweat JM, Pandharkar T, Stephens CE, Riccio E, Parman T, Munde M, Mandal S, Madhubala R, Tidwell RR, Wilson WD, Boykin DW, Hall JE, Kyle DE, Werbovetz KA.

Antimicrob Agents Chemother. 2010 Jun;54(6):2507-16. doi: 10.1128/AAC.00250-10. Epub 2010 Apr 5.

13.

Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1.

Furimsky AM, Green CE, Sharp LE, Catz P, Adjei AA, Parman T, Kapetanovic IM, Weinshilboum RM, Iyer LV.

Drug Metab Dispos. 2008 Jan;36(1):129-36. Epub 2007 Oct 22.

PMID:
17954528
14.

RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.

Mamidipudi V, Dhillon NK, Parman T, Miller LD, Lee KC, Cartwright CA.

Oncogene. 2007 May 3;26(20):2914-24. Epub 2006 Oct 30.

PMID:
17072338
16.

Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.

Wells PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC, Kim PM, Laposa RR, McCallum GP, Nicol CJ, Parman T, Wiley MJ, Wong AW.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):354-66. Review.

PMID:
16081118
17.

A mental health screening project in Istanbul, Turkey.

Baysal SU, Ozmen B, Parman T, Sahip Y, Bulut A, Gökçay G.

J Sch Health. 2004 Oct;74(8):341-3. No abstract available.

PMID:
15554121
18.
19.

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.

Parman T, Wiley MJ, Wells PG.

Nat Med. 1999 May;5(5):582-5.

PMID:
10229238
21.

Oxidative damage in chemical teratogenesis.

Wells PG, Kim PM, Laposa RR, Nicol CJ, Parman T, Winn LM.

Mutat Res. 1997 Dec 12;396(1-2):65-78. Review.

PMID:
9434860

Supplemental Content

Loading ...
Support Center